SF3B4 and hepatocellular carcinoma: Clinical validation confirmed the co-upregulation of SF3B4 and SREBF1 in HCC tissues.<h4>Conclusion</h4>This study reveals a novel post-transcriptional mechanism in which SF3B4 promotes HCC progression by stabilizing SREBF1 mRNA through direct 3'UTR binding.